Anti-Spike (S) SARS-CoV-2 monoclonal antibodies

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-Spike (S) SARS-CoV-2 monoclonal antibodies, covering 2023-12-21 to 2023-12-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19 [Phase 3]

See pricing